The site is undergoing maintenance on
Friday, September 11, 2:00 am through Saturday, September 12, 2:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Friday, September 11, 2:00 am through Saturday, September 12, 2:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Friday, September 11, 2:00 am through Saturday, September 12, 2:00 am (CEST), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of CD185 (CXCR5) expression on mouse splenocytes. Left Panel: Splenocytes from C57BL/6 mice were stained either with a APC Rat IgG2a, κ isotype control (Cat. No. 553932; shaded histogram) or with the APC Rat Anti-Mouse CD185 (CXCR5) antibody (Cat. No. 560615; unshaded histogram). Histograms were derived from gated events based on light scattering characteristics for CD45R/B220+ cells. Middle and Right Panels: Splenocytes from C57BL/6 mice were stained with both FITC Rat Anti-Mouse CD45R/B220 antibody (Cat.No. 553088) and either an APC Rat IgG2a, κ isotype control (middle panel) or the APC Rat Anti-Mouse CD185 (CXCR5) antibody (right panel). Dot plots were derived from gated events based on light scattering characteristics for splenocytes. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Flow cytometric analysis of CD185 (CXCR5) expression on mouse splenocytes. Left Panel: Splenocytes from C57BL/6 mice were stained either with a APC Rat IgG2a, κ isotype control (Cat. No. 553932; shaded histogram) or with the APC Rat Anti-Mouse CD185 (CXCR5) antibody (Cat. No. 560615; unshaded histogram). Histograms were derived from gated events based on light scattering characteristics for CD45R/B220+ cells. Middle and Right Panels: Splenocytes from C57BL/6 mice were stained with both FITC Rat Anti-Mouse CD45R/B220 antibody (Cat.No. 553088) and either an APC Rat IgG2a, κ isotype control (middle panel) or the APC Rat Anti-Mouse CD185 (CXCR5) antibody (right panel). Dot plots were derived from gated events based on light scattering characteristics for splenocytes. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Flow cytometric analysis of CD185 (CXCR5) expression on mouse splenocytes. Left Panel: Splenocytes from C57BL/6 mice were stained either with a APC Rat IgG2a, κ isotype control (Cat. No. 553932; shaded histogram) or with the APC Rat Anti-Mouse CD185 (CXCR5) antibody (Cat. No. 560615; unshaded histogram). Histograms were derived from gated events based on light scattering characteristics for CD45R/B220+ cells. Middle and Right Panels: Splenocytes from C57BL/6 mice were stained with both FITC Rat Anti-Mouse CD45R/B220 antibody (Cat.No. 553088) and either an APC Rat IgG2a, κ isotype control (middle panel) or the APC Rat Anti-Mouse CD185 (CXCR5) antibody (right panel). Dot plots were derived from gated events based on light scattering characteristics for splenocytes. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Flow cytometric analysis of CD185 (CXCR5) expression on mouse splenocytes. Left Panel: Splenocytes from C57BL/6 mice were stained either with a APC Rat IgG2a, κ isotype control (Cat. No. 553932; shaded histogram) or with the APC Rat Anti-Mouse CD185 (CXCR5) antibody (Cat. No. 560615; unshaded histogram). Histograms were derived from gated events based on light scattering characteristics for CD45R/B220+ cells. Middle and Right Panels: Splenocytes from C57BL/6 mice were stained with both FITC Rat Anti-Mouse CD45R/B220 antibody (Cat.No. 553088) and either an APC Rat IgG2a, κ isotype control (middle panel) or the APC Rat Anti-Mouse CD185 (CXCR5) antibody (right panel). Dot plots were derived from gated events based on light scattering characteristics for splenocytes. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Flow cytometric analysis of CD185 (CXCR5) expression on mouse splenocytes. Left Panel: Splenocytes from C57BL/6 mice were stained either with a APC Rat IgG2a, κ isotype control (Cat. No. 553932; shaded histogram) or with the APC Rat Anti-Mouse CD185 (CXCR5) antibody (Cat. No. 560615; unshaded histogram). Histograms were derived from gated events based on light scattering characteristics for CD45R/B220+ cells. Middle and Right Panels: Splenocytes from C57BL/6 mice were stained with both FITC Rat Anti-Mouse CD45R/B220 antibody (Cat.No. 553088) and either an APC Rat IgG2a, κ isotype control (middle panel) or the APC Rat Anti-Mouse CD185 (CXCR5) antibody (right panel). Dot plots were derived from gated events based on light scattering characteristics for splenocytes. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Flow cytometric analysis of CD185 (CXCR5) expression on mouse splenocytes. Left Panel: Splenocytes from C57BL/6 mice were stained either with a APC Rat IgG2a, κ isotype control (Cat. No. 553932; shaded histogram) or with the APC Rat Anti-Mouse CD185 (CXCR5) antibody (Cat. No. 560615; unshaded histogram). Histograms were derived from gated events based on light scattering characteristics for CD45R/B220+ cells. Middle and Right Panels: Splenocytes from C57BL/6 mice were stained with both FITC Rat Anti-Mouse CD45R/B220 antibody (Cat.No. 553088) and either an APC Rat IgG2a, κ isotype control (middle panel) or the APC Rat Anti-Mouse CD185 (CXCR5) antibody (right panel). Dot plots were derived from gated events based on light scattering characteristics for splenocytes. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Flow cytometry: Chemokine receptors are known to internalize during manipulation resulting in low frequency expression. Investigators are advised to perform immunophenotyping studies of chemokine receptors on freshly collected samples (<24 Hrs). Incubation with the antibody should be done at 4°C in the dark. Cellular manipulation, such as Ficoll separation, freezing, or exposure to cold temperatures prior to staining should be minimized and have been shown to cause a decrease in staining intensity and/or inconsistent results.
Investigators should note that alternative staining procedures may be necessary. A multiple-step staining procedure is strongly recommended, in some instances, to amplify immunofluorescent signals for the flow cytometric analysis of mouse CXCR5 expression. Investigators may find the Purified Rat Anti-Mouse CXCR5 antibody (Cat. No. 551961) to be useful in conjunction with appropriate secondary and tertiary reagents for detecting low frequency expression, such as with Biotin Mouse Anti-Rat IgG2a (Cat. No. 553894) and PE Streptavidin (Cat. No. 554061) or FITC Streptavidin (Cat. No. 554060).
The 2G8 monoclonal antibody specifically binds to the mouse C-X-C Chemokine Receptor type 5, CXCR5. CXCR5 is also known as CD185, BLR1, NLR and MDR15. CXCR5 is a seven-transmembrane, G-protein-coupled receptor that is specific for the CXC chemokine, CXCL13/BLC/BCA-1. The expression of CXCR5 has been detected in spleen, lymph nodes, tonsils, brain, bone marrow, T cells, B cells, cerebrum, cerebellum, hippcampus and pituitary. In mouse spleen, CXCR5 was strictly expressed by mature B cells and a small subset of T lymphocytes. CXCR5 plays a role in directing the migration of B and T cells to B cell follicles with the spleen and certain other lymphoid tissues. The immunogen used to generate 2G8 hybridoma was a recombinant protein containing N-terminal amino acids of mouse CXCR5 (GST-NmBLR1).
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.